| PERIOD ENDING | 30-Sep-09 | 1-Jul-09 | 8-Apr-09 | 17-Dec-08 | | Total Revenue | 159,987 | 146,349 | 189,029 | 131,677 | | Cost of Revenue | 123,047 | 111,694 | 147,137 | 106,713 | | | Gross Profit | 36,940 | 34,655 | 41,892 | 24,964 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 21,127 | 19,693 | 25,390 | 19,694 | | Non Recurring | 2,723 | (983) | 729 | 176 | | Others | 7,527 | 6,913 | 9,537 | 7,392 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 5,563 | 9,032 | 6,236 | (2,298) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (338) | 419 | (81) | | Earnings Before Interest And Taxes | (5,778) | 8,694 | 6,655 | (2,379) | | Interest Expense | (10,998) | 3,347 | 4,049 | 3,602 | | Income Before Tax | 5,220 | 5,347 | 2,606 | (5,981) | | Income Tax Expense | 1,807 | 1,544 | 353 | (2,541) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,382 | 3,803 | 2,253 | (3,440) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,382 | 3,803 | 2,253 | (3,440) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,382 | $3,803 | $2,253 | ($3,440) |
|
0.01% Nasdaq 
Income Statement
